RNA, Cell, Protein, & Vector Engineering
Enabling the manufacturing, development and design of cell and gene therapies through engineering
// Technology
Platforms
Engineering at the Center of Cell and Gene Therapy Innovation
We have built multiple engineering technology platforms that are essential to the construct, design, and scaling of cell and gene therapies. Through our engineering technologies, we have centralized these technologies to ensure internal programs and external partners have access to the necessary tools to build novel therapies.
An Integrated Ecosystem of Engineering Technology
Each engineering platform is fully integrated within the ElevateBio® ecosystem to improve productivity and scalability of the therapies we develop and manufacture.
RNA, Cell, Protein, & Vector Engineering
RNA EngineeringWe are developing novel technologies to deliver RNA molecules to cells to provide genetic instructions to make specific proteins, which can treat or prevent disease, or to disrupt the production of disease-causing proteins. |  |
Protein EngineeringOur protein engineering platform can help improve the efficiency and specificity of new technologies, including the continued advancement of antigen receptors, binders, and endonucleases. |  |
Vector EngineeringOur viral vector engineering technologies can support all stages of development, including gene delivery and end-to-end process development and manufacturing for lentiviral and adeno-associated virus (AAV) vectors, across different cell types and payloads. |  |
Our Integrated Technology Platforms Fueling the Discoveries of Tomorrow
Gene
Editing
We have a powerful suite of proprietary gene editing technologies to accelerate the development of life-changing and curative therapies for patients.
Cell Therapy Enabling Technologies
Our technologies and capabilities can enable a range of cell-based therapies, including those derived from T cells, NK cells, induced pluripotent stem cells, and more.
Our Therapeutic Approaches
We are enabling the development of a range of ex vivo and in vivo cell and gene therapies, leveraging our in-house capabilities and expertise to design and develop an array of modalities.
End-to-End Capabilities
We help our partners scale new heights in cell and gene therapies by providing a full spectrum of viral vector and cell therapy capabilities to bring concepts to commercialization.
Partner with ElevateBio®
Wherever you are in your product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.
// Work with us
